Selumetinib in women with recurrent low-grade serous carcinoma of the ovary or peritoneum: an open-label, single-arm, phase 2 study

Authors: John Farley, William E. Brady, Vinod Vathipadiekal, Heather A. Lankes, Robert L. Coleman, Mark A. Morgan, Robert S. Mannel, S. Diane Yamada, David G. Mutch, William H. Rodgers, Michael J. Birrer, David M. Gershenson - The Lancet 2012 cited by 413